Manning Meredith

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Manning Meredith's trades of Soleno Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-31 2026-03-27
S Sale
15,603 -5.8%
194.88
US$3,713,763 		15,603 -5.8% 194.88 US$3,713,763
2026-03-31 2026-03-27
S Sale
38,892 -14.3%
443.89
US$1,520,880 		38,892 -14.3% 443.89 US$1,520,880
2026-03-31 2026-03-27
S Sale
8,206 +6.1%
397.10
US$2,795,936 		8,206 +6.1% 397.10 US$2,795,936
2025-03-31 2025-03-27
S Sale
37,000 -44.9%
67.04
US$2,480,436 		37,000 -44.9% 67.04 US$2,480,436
2025-03-31 2025-03-27
S Sale
34 -0.1%
72.64
US$2,470 		34 -0.1% 72.64 US$2,470
2025-03-31 2025-03-27
S Sale
225 -0.5%
71.74
US$16,142 		225 -0.5% 71.74 US$16,142
2025-03-31 2025-03-27
S Sale
155 -0.3%
70.73
US$10,964 		155 -0.3% 70.73 US$10,964
2025-03-31 2025-03-27
S Sale
1,505 -3.2%
69.84
US$105,105 		1,505 -3.2% 69.84 US$105,105
2025-03-31 2025-03-27
S Sale
2,599 -5.2%
68.79
US$178,780 		2,599 -5.2% 68.79 US$178,780
2025-03-31 2025-03-27
S Sale
1,976 -3.8%
67.70
US$133,777 		1,976 -3.8% 67.70 US$133,777
2025-03-31 2025-03-27
S Sale
1,087 -2.1%
66.79
US$72,602 		1,087 -2.1% 66.79 US$72,602
2025-03-31 2025-03-27
S Sale
668 -1.2%
65.97
US$44,067 		668 -1.2% 65.97 US$44,067
2025-03-27 2025-03-27
PrS Proposed sale
48,000
50.05
US$2,402,400 		48,000 50.05 US$2,402,400